|
|
| ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate |
|
| CHEBI:84883 |
|
| ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate |
|
| A long-chain fatty acid ethyl ester resulting from the formal condensation of the carboxy group of (5Z,8Z,11Z,14Z,17Z)-icosapentaenoic acid with the hydroxy group of ethanol. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
CHEBI:80366
|
|
|
|
|
|
Molfile
XML
SDF
|
|
|
more structures >>
|
|
|
|
InChI=1S/C22H34O2/c1- 3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17- |
| SSQPWTVBQMWLSZ-AAQCHOMXSA-N |
| C(\CC)=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC |
|
|
marine metabolite
Any metabolite produced during a metabolic reaction in marine macro- and microorganisms.
|
|
|
anticholesteremic drug
A substance used to lower plasma cholesterol levels.
antipsychotic agent
Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
antidepressant
Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
|
|
View more via ChEBI Ontology
|
Outgoing
|
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
(CHEBI:84883)
has functional parent
all-cis-5,8,11,14,17-icosapentaenoic acid
(CHEBI:28364)
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
(CHEBI:84883)
has role
anticholesteremic drug
(CHEBI:35821)
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
(CHEBI:84883)
has role
antidepressant
(CHEBI:35469)
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
(CHEBI:84883)
has role
antipsychotic agent
(CHEBI:35476)
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
(CHEBI:84883)
has role
marine metabolite
(CHEBI:76507)
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
(CHEBI:84883)
has role
prodrug
(CHEBI:50266)
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
(CHEBI:84883)
is a
long-chain fatty acid ethyl ester
(CHEBI:13209)
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate
(CHEBI:84883)
is a
polyunsaturated fatty ester
(CHEBI:145039)
|
|
|
ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
|
|
(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid ethyl ester
|
KEGG COMPOUND
|
|
(all-Z)-5,8,11,14,17-Eicosapentaenoic acid ethyl ester
|
ChemIDplus
|
|
all-cis-ethyl 5,8,11,14,17-icosapentaenoate
|
ChEBI
|
|
AMR 101
|
ChemIDplus
|
|
AMR101
|
ChemIDplus
|
|
cis-Eicosapentaenoic acid ethyl ester
|
ChemIDplus
|
|
E-EPA
|
ChEBI
|
|
Eicosapentaenoic acid ethyl ester
|
ChemIDplus
|
|
EPA ethyl ester
|
KEGG COMPOUND
|
|
ethyl (5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoate
|
ChEBI
|
|
ethyl (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate
|
ChEBI
|
|
Ethyl (all cis)-5,8,11,14,17-icosapentaenoate
|
HMDB
|
|
Ethyl all-cis-5,8,11,14,17-icosapentaenoate
|
HMDB
|
|
Ethyl eicosapentaenoate
|
ChemIDplus
|
|
Ethyl icosapentate
|
HMDB
|
|
Icosapent ethyl
|
ChemIDplus
|
|
Timnodonic acid ethyl ester
|
ChemIDplus
|
|
Epadel
|
ChemIDplus
|
|
Vascepa
|
ChemIDplus
|
|
4811237
|
Reaxys Registry Number
|
Reaxys
|
|
86227-47-6
|
CAS Registry Number
|
KEGG COMPOUND
|
|
86227-47-6
|
CAS Registry Number
|
ChemIDplus
|
|
22819432
|
PubMed citation
|
Europe PMC
|
|
22894624
|
PubMed citation
|
Europe PMC
|
|
23312052
|
PubMed citation
|
Europe PMC
|
|
23325450
|
PubMed citation
|
Europe PMC
|
|
23701295
|
PubMed citation
|
Europe PMC
|
|
23835245
|
PubMed citation
|
Europe PMC
|
|
23992935
|
PubMed citation
|
Europe PMC
|
|
24075771
|
PubMed citation
|
Europe PMC
|
|
24259598
|
PubMed citation
|
Europe PMC
|
|
24516343
|
PubMed citation
|
Europe PMC
|
|
24760401
|
PubMed citation
|
Europe PMC
|
|
24973042
|
PubMed citation
|
Europe PMC
|
|
24977343
|
PubMed citation
|
Europe PMC
|
|
25028554
|
PubMed citation
|
Europe PMC
|
|
25428605
|
PubMed citation
|
Europe PMC
|
|
25471740
|
PubMed citation
|
Europe PMC
|
|
25515964
|
PubMed citation
|
Europe PMC
|
|
